logo
Outdoors: Chronic Wasting Disease isn't coming – it's here

Outdoors: Chronic Wasting Disease isn't coming – it's here

Yahoo16-02-2025
When the presence of Chronic Wasting Disease was first discovered in Pennsylvania deerhalf a state away, locally the reaction was one of superficial concern.
Wishful thinking was that the always-fatal neurological disease caused by a misfoldedprotein called prions in deer and elk would somehow contain itself. CWD is atransmissible spongiform encephalopathy and is similar to scrapie in sheep, mad cowdisease in cattle and Creutzfeldt-Jakob disease in humans.
Little by little, however, CWD moved closer and closer to the area until only those whoclaimed the disease was a hoax by the Pennsylvania Game Commission as an excuse to'kill more deer' understood it was not a matter if it would affect our area, but when. Twoweeks ago when became now after the PGC in conjunction with the PennsylvaniaDepartment of Agriculture, announced two deer had tested positive for CWD in a newarea of Pennsylvania. Two matured bucks — one taken by a hunter and one from a captivefacility — were detected with CWD in Luzerne County, 40 miles from the nearest wildCWD detection.
They will ultimately result in Disease Management Area changes later this spring – thedetails of which will be released following the Board of Game Commissioners meeting inApril. Certainly the presence of CWD in our backyard is unsettling, but as bad as thatnews was, last week it got worse when CWD was discovered on our doorstep when amature buck was detected in Packer Township, Carbon County.
This detection is the first in Carbon County and is more than 10 miles from any otherconfirmed CWD-positive deer. The deer was found dead by a landowner and wasseverely emaciated.
In Luzerne County the captive deer that tested positive for CWD in December was from abreeding deer farm. Initial positive test results from the Pennsylvania Animal DiagnosticSystem Laboratory were confirmed in the USDA's National Veterinary ServicesLaboratory in Ames, Iowa, December 23.
The Pennsylvania Department of Agriculture placed the farm under a quarantine order forfive years. The order requires the farm to test any additional deer that die on the farm,and not transfer any deer on or off the farm, and any subsequent positive test results willextend the quarantine order requirements and restrictions for another five years.
Pennsylvania deer farms must participate in one of two stringent programs – the HerdCertified Program, or the Herd Monitored Program. The Herd Certified Program meetsU.S. Department of Agriculture CWD standards and is required for any cervid farmerwishing to ship deer across state lines. Both programs require proper IDs; record-keepingon all animals moved on or off farms; annual herd inventories; reporting of CWD suspectanimals and animals that die, escape or are stolen; maintaining a minimum 8-foot-highfence; obtaining permits to import animals from out-of-state; and other measures tomonitor herds for disease. Only farms enrolled in the Herd Certified Program arepermitted to move live deer across state lines, with official identification that will aid veterinarians in tracking disease origins in the event remaining deer die and testpositive.
CWD spreads through direct animal-to-animal contact, as well as indirectly throughprion-contaminated environments. CWD-infected deer shed prions through saliva, urineand feces, and infected carcasses contribute to environmental contamination.
Once in soil, CWD prions remain infectious for decades. Therefore, feeding deer isstrongly discouraged and is illegal within existing DMAs.
There is no evidence of CWD infecting humans or other species under natural conditions,however, much is still unknown about CWD, therefore the Centers for Disease Controland Prevention recommends not eating the meat of a CWD-positive deer. ChronicWasting Disease programs in captive deer are managed by the PA Department ofAgriculture and are necessary to help slow the spread of the disease and allow thesebusinesses to operate.
The PGC will host an informational meeting to answer questions from the public,Thursday, Feb. 27, form 6-8 p.m., at Penn State Hazleton, Graham Building Room 115,Parking Lot F, 76 University Drive, Hazleton 18202. For information contact the PGCCWD Hotline at 1-833-INFOCWD, email INFOCWD@pa.gov or go towww.arcg.is/1G4TLr .
(Dietz is a member of the Pennsylvania Outdoor Writers Association)Contact the writer: outdoors@republicanherald.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sask. enforcing mandatory CWD and bovine TB testing in select zones for upcoming hunting season
Sask. enforcing mandatory CWD and bovine TB testing in select zones for upcoming hunting season

Yahoo

time13 hours ago

  • Yahoo

Sask. enforcing mandatory CWD and bovine TB testing in select zones for upcoming hunting season

White-tailed deer, mule deer and elk now must be tested in several wildlife management zones (WMZs) in Saskatchewan during the upcoming hunting season. The mandatory tests are to detect cases of chronic wasting disease (CWD), as well as bovine tuberculosis (TB), which many are concerned could be transmitted through game animals. Darrell Crabbe is the executive director of the Sask. Wildlife Federation. His organization has been calling for mandatory testing since 2019. "The mandatory testing for CWD and these other areas are as much for an expansion of an agricultural process than it is about the science," Crabbe said. "It happens to provide us some good information on prevalence in some zones that historically haven't had any." The province said mandatory CWD testing will be conducted in WMZs 43, 47, 50 and 55. On top of that, in response to confirmed cases in two separate cattle herds in 2023 and 2024, mandatory bovine tuberculosis testing will take place in WMZs 37 and 39. You can see what WMZ an area falls under using the province's interactive map. "Historically we didn't have a whole bunch of information in those zones that they're talking about here, so it'll be good to have some of that data to work with," Crabbe said. "We firmly believe that hunters should always be at the front of the line to assist with citizen science to try to rectify any of these types of conditions we have to deal with." In a statement released on Monday, Environment Minister Travis Keisig said monitoring wildlife health protects the hunting and agriculture economies. "We rely on hunters to submit samples for testing, and we appreciate their co-operation and thank them for their continued support," Keisig said. According to the 2023-24 CWD Surveillance Program, Saskatchewan had some of the highest rates of the disease in North America. Hunters harvesting any deer or elk in those zones will have to submit the animals' heads for testing within one month of death or by Jan. 21, 2026, whichever comes first. The provincial government and the Sask. Wildlife Federation encourage hunters to voluntarily submit samples in all zones outside of those with mandatory testing, to get a better sense of the spread. Drop-off locations will be available throughout the province and testing is free. The Ministry of Environment said it will also be adding more bins for the safe disposal of carcasses or meat from CWD positive animals.

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit
IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

Business Wire

timea day ago

  • Business Wire

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced positive topline results from the randomized, phase III IMvigor011 clinical trial in muscle-invasive bladder cancer (MIBC). The trial is sponsored by Genentech, a member of the Roche Group. IMvigor011 utilizes the Signatera ctDNA test in patients with MIBC to detect molecular residual disease (MRD) in the bloodstream after surgery and predict who will benefit from adjuvant treatment with the cancer immunotherapy atezolizumab (Tecentriq®). Approximately 760 patients were enrolled in the surveillance phase of the trial and underwent serial Signatera testing for up to 12 months post surgery. Patients were randomized to treatment with atezolizumab or placebo if they tested Signatera-positive and remained free of cancer recurrence on imaging with treatment administered every 4 weeks for 12 cycles or up to one year. Patients who consistently tested Signatera-negative were not randomized to treatment but continued to be followed up with radiographic imaging and ctDNA MRD testing. Topline results from IMvigor011 demonstrated a statistically significant and clinically meaningful improvement in disease-free survival and overall survival for Signatera-positive patients treated with atezolizumab. Natera expects trial data to be presented at an upcoming medical conference. 'The results of IMvigor011 are very significant, opening the door for a new treatment paradigm for bladder cancer patients who are positive for recurrence on a molecular level but have no evidence of disease on imaging,' said Professor Thomas Powles, MBBS, MRCP, M.D., lead principal investigator of the study; Barts Cancer Institute QMUL. 'We look forward to presenting the positive results later this year.' 'Importantly, IMvigor011 could change how resectable bladder cancer is managed for the tens of thousands of patients diagnosed with MIBC each year,' said Alexey Aleshin, M.D., general manager of oncology and corporate chief medical officer at Natera. Natera will finalize its premarket approval application to the U.S. Food and Drug Administration for Signatera as a companion diagnostic for the selection of patients with MIBC to be treated with atezolizumab after cystectomy. In addition to the topline result released today, a preliminary analysis of Signatera-negative patients from IMvigor011 was presented at the European Association of Urology in April 2024. The data highlighted that post-operative patients who remain Signatera-negative on serial testing had excellent outcomes without adjuvant treatment. The analysis showed that 171 patients who remained Signatera-negative during the surveillance window had overall survival rates of 100% at 12 months and 98% at 18 months, and disease-free survival rates of 92% at 12 months and 88% at 18 months after surgery. Notes Tecentriq® (atezolizumab) is a registered trademark of Genentech, a member of the Roche Group. *ctDNA MRD = circulating tumor DNA molecular residual disease About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are supported by more than 300 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit Forward-Looking Statements All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in 'Risk Factors' in Natera's recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at and

Senegal's ‘schools for husbands' aim to shift gender roles and keep mothers from dying
Senegal's ‘schools for husbands' aim to shift gender roles and keep mothers from dying

Yahoo

time2 days ago

  • Yahoo

Senegal's ‘schools for husbands' aim to shift gender roles and keep mothers from dying

Senegal School For Husbands DAKAR, Senegal (AP) — On a recent evening in Senegal 's capital of Dakar, an imam named Ibrahima Diane explained to a group of men why they should be more involved in household chores. 'The Prophet himself says a man who does not help support his wife and children is not a good Muslim,' the 53-year-old said, as he described bathing his baby and helping his wife with other duties. Some of the 14 men chuckled, not quite sold. Others applauded. Diane was taking part in a 'school for husbands,' a United Nations-backed initiative where respected male community members learn about 'positive masculinity' in health and social issues and promote them in their communities. In Senegal, as in many other West African countries with large rural or conservative populations, men often have the final say in major household decisions, including ones related to health. Women may need their permission for life-changing decisions on accessing family planning or other reproductive health services, along with hospital deliveries or prenatal care. Following his sessions at the school for husbands, Diane regularly holds sermons during Friday prayers where he discusses issues around gender and reproductive health, from gender-based violence to fighting stigma around HIV. 'Many women appreciate my sermons," he said. 'They say their husbands' behavior changed since they attended them." He said some men have told him the sermons inspired them to become more caring husbands and fathers. Habib Diallo, a 60-year-old former army commando, said attending the sermons and discussions with the imam taught him about the risks of home births. 'When my son's wife was pregnant, I encouraged him to take her to the hospital for the delivery,' Diallo said. 'At first, he was hesitant. He worried about the cost and didn't trust the hospital. But when I explained how much safer it would be for both his wife and the baby, he agreed.' No more barking orders The program launched in Senegal in 2011 but in recent years has caught the attention of the Ministry of Women, Family, Gender and Child Protection, which sees it an effective strategy to combat maternal and infant mortality. 'Without men's involvement, attitudes around maternal health won't change," said 54-year-old Aida Diouf, a female health worker who collaborates with the program. Many husbands prefer their wives not be treated by male health workers, she said. The classes for husbands follow similar efforts in other African countries, particularly Niger, Togo, and Burkina Faso, where the United Nations Population Fund says it improved women's access to reproductive health services by increasing male involvement, growing the use of contraceptives by both men and women and expanding access to prenatal care and skilled birth attendants. Discussions for men also have focused on girls' rights, equality and the harmful effects of female genital mutilation. The program now operates over 20 schools in Senegal, and over 300 men have been trained. In some communities, men who once enforced patriarchal norms now promote gender equality, which has led to a reduction in the number of forced marriages and more acceptance of family planning, according to Senegal's ministry of gender. Men join the groups after being recruited based on trust, leadership and commitment. Candidates must be married, respected locally and supportive of women's health and rights. After training, the men act as peer educators, visiting homes and hosting informal talks. 'My husband used to not do much around the house, just bark orders. Now he actually cooks and helps out with daily tasks,' said Khary Ndeye, 52. Still too many dying in childbirth While maternal and infant deaths in Senegal have declined over the past decade, experts say it still has a long way to go. It recorded 237 maternal deaths for every 100,000 live births in 2023, while 21 newborns out of every 1,000 died within their first month. The U.N. globally wants to reduce maternal deaths to 70 deaths per 100,000 live births and newborn deaths to under 12 per 1,000 by 2030. One key problem was that many women have been giving birth at home, said El Hadj Malick, one of the Senegal program's coordinators. 'By educating men about the importance of supporting their wives during pregnancy, taking them to the hospital and helping with domestic work at home, you're protecting people's health,' Malick said. He said he still experiences difficulty changing mindsets on some issues. 'When we just talk to them about gender, there is sometimes tension because it's seen as something abstract or even foreign,' Malick said. Some men mistakenly believe such talk will promote LGBTQ+ issues, which remain largely taboo in much of West Africa. "But when we focus on women's right to be healthy, it puts a human face on the concept and its becomes universal,' Malick said. ___ For more on Africa and development: ___ The Associated Press receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store